Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

Carmen C.  Solorzano

Carmen C. Solorzano, M.D., F.A.C.S.

Professor of Surgery
Chief, Division of Surgical Oncology & Endocrine Surgery
Director, Vanderbilt Endocrine Surgery Center
Chief of General Surgery, VA Tennessee Valley Health Care System, Nashville Campus
Surgical Oncologist


Dr. Solorzano specializes in minimally invasive parathyroidectomy, initial and re-operative management of thyroid cancer, laparoscopic and open adrenalectomy for adrenal tumors, pheochromocytoma, insulinoma, gastrinoma, complex pancreatic resections for endocrine tumors of the pancreas (Whipple,enucleations), and the surgical management of patients with multiple endocrine neoplasia and other inherited endocrine diseases/cancers. Dr. Solorzano has published more than 70 peer reviewed articles and chapters relating to Endocrine Surgery research.

  • B.S., University of Florida
  • M.D., University of Florida
  • General Surgery, University of Florida
  • Surgical Oncology/Endocrine Fellowship, UT MD Anderson Cancer Center
Clinical Research Description

My research deals with the use of surgeon performed ultrasound to predict thyroid cancer in patients with indeterminate cytology and to localize parathyroid glands prior to parathyroidectomy. In addition I collaborate with basic scientist to grow thyroid cancer cells and create new thyroid cancer cell lines. With these new thyroid cancer cell lines we have started to study the role of estrogen in thyroid cancer. Ultimately the clinical history will be correlated with the laboratory findings. I am also interested and actively working on the creation of clinical databases (linked to tissue banks) that can be shared nationally and interanationally to better understand rare endocrine surgical diseases.